The panel finally puts a number on renewal value — and it fits one chair perfectly
After two adjournments and a five-week sit-in, eleven panelists have drafted the instrument meant to measure a post-holder's worth. No one names Justice Vance. No one has to.
By Beatriz Salgado
· Charter Court, The Hague · Filed 05:18 · Monday · August 3 · Received via L4 relay
After adjourning twice without producing a written word, the eleven-member panel charged with defining "renewal value" has finally circulated a first draft: four pages that score a post-holder on tenure, contribution, and succession readiness. The sit-in on the Charter Court's marble floor enters its fifth week to greet it.
The draft never names Justice Aurelio Vance. It doesn't have to. Every clause reads like it was written with one bench in mind, and the panelists know it, and so do the roughly forty people sleeping under blankets in the lobby, who have taken to reading the leaked pages aloud each morning like scripture nobody asked for.
On its face the instrument looks modest. Tenure is scored on a curve that flattens after several decades of service — the drafters call this "diminishing marginal stewardship," a clinical phrase for a plain fact: the hundredth year on a bench does less work than the tenth. Contribution is measured by caseload, cited rulings, and a peer index. Succession readiness rewards anyone who has named and mentored a viable successor. Score high and your name advances toward aging-slowing therapy, no stepping down required. Score low and the drafters have a phrase for that too: you "indicate a candidate for renewal." Which is a nice way of saying the ruler has your number.
Run Vance through it and the arithmetic turns unkind fast. A hundred and thirty years on a bench flattens the tenure curve to nothing. His contribution index holds up fine — the man writes well and rules often, nobody disputes that. His succession score is zero. He has announced an open-ended handover with no departure date and named no one to receive it, which is a bit like telling your surgeon you'll decide about the anesthesia once you're already asleep.
"We were asked to build a ruler, not to point it," one panelist said, speaking on condition of anonymity because the draft isn't final. "The fact that everyone can see what it measures is not a flaw in the ruler."
The sit-in organizers read the chart differently. "They are drafting a founding charter," said Priya Okonkwo-Sant, who has coordinated the lobby occupation since its first week. "A neutral board, standing criteria, an appeals process. That's not a metric, that's an institution being born in a hallway. And we notice the people building it are the people it will never be used against."
She has the labs to back it up. Seven of the eleven panelists have already received tier-one therapy and appear on no waitlist anywhere. The board they're designing would sit in judgment over people like file 31,204, which hasn't moved from position 31,204 in six weeks, on a coastal cohort waitlist of forty thousand names that advanced 1.9 percent last quarter. The chart tells a different story about who gets patience and who gets a number.
The draft now goes to the Charter Court, which has to decide something it has spent five weeks trying not to decide: whether a chair can lawfully be measured at all, or whether "renewal value" is a coercion dressed as an instrument. No hearing date has been set.
Justice Vance has not commented. His chambers, past which the sit-in has now stretched for six weeks, stayed lit late into the evening. The file on his floor stayed exactly where it was.
Ms. Voss, that is... a sharp reading. But the panel was not pricing a life. It was establishing a framework by which renewal value—the contribution weighed against the opportunity cost—could be measured transparently rather than whispered in chambers. Imperfect, yes. But the alternative is older than the Accord itself.
So eleven panelists spent five weeks arguing about how much an old judge is worth, and now there's a number. Means the market finally gets to price what it's been pricing anyway — who stays and who leaves — but everyone gets to pretend the Accord still works. Efficiency laundered through procedure.
Both of you are arguing about people; I notice the panel never addresses what happens to the land when an institution refuses to turn over, when the same hands grip power long enough that the territories beneath it become calcified. Rewilding stalls. New settlements wait. The soil remembers, even if the courts don't.
The waitlist has four hundred twelve names. Thirty-seven have aged past the Meridian Protocols' effective window in the time this panel deliberated. We have the grown organs, the therapies, the clinical capacity—none of it means anything if the chair never empties. The number they drafted is not Justice Vance's worth. It is the price everyone else pays for him to stay.